Deaths from Clostridium sordellii after medical abortion [13]

New England Journal of Medicine

Volumn 354, Issue 15, 2006, Pages 1645-1646

  Baulieu, Etienne Emile ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; MIFEPRISTONE; MISOPROSTOL; PROSTAGLANDIN; ABORTIVE AGENT;

ANTIBIOTIC PROPHYLAXIS; CLOSTRIDIUM SORDELLII; HUMAN; INDUCED ABORTION; LETTER; METRITIS; MORTALITY; PRIORITY JOURNAL; BACTERIAL INFECTION; FEMALE; MATERNAL MORTALITY; MICROBIOLOGY; NOTE; PREGNANCY; SEPTIC SHOCK; UNITED STATES; ORAL DRUG ADMINISTRATION; ENDOMETRITIS; FRANCE; INTRAVAGINAL DRUG ADMINISTRATION;

ABORTIFACIENT AGENTS; ABORTION, INDUCED; CLOSTRIDIUM INFECTIONS; CLOSTRIDIUM SORDELLII; FEMALE; HUMANS; MATERNAL MORTALITY; PREGNANCY; SHOCK, SEPTIC; UNITED STATES; ADMINISTRATION, ORAL; ANTIBIOTIC PROPHYLAXIS; MIFEPRISTONE; MISOPROSTOL; ADMINISTRATION, INTRAVAGINAL; ENDOMETRITIS; FRANCE;

EID: 33645762574     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc055539     Document Type: Letter

References (7)

1. Peyron R, Aubény E, Targosz V, et al. Early pregnancy interruption with RU 486 (mifepristone) and misoprostol, an orally active prostaglandin analogue. N Engl J Med 1993;328:1509-13.
2. Aubény E. A two-stage increase in the dose of misoprostol improves the efficacy of medical abortion with mifepristone and prostaglandins. Eur J Contracept Reprod Health Care 2001;6:54-5.
3. Sitruk-Ware R. Mifepristone and misoprostol: sequential regimen side-effects, complications and safety. Contraception (in press).
4. Fischer M, Bhatnagar J, Guarner J, et al. Fatal toxic shock syndrome associated with Clostridium sordellii after medical abortion. N Engl J Med 2005;353:2352-60.
5. Greene MF. Fatal infections associated with mifepristone-induced abortion. N Engl J Med 2005;353:2317-8.
6. Ashok PW, Templeton A, Wagaarachchi PT, Flett GM. Factors affecting the outcome of early medical abortion: a review of 4132 consecutive cases. BJOG 2002;109:1281-9.
7. Fiala C. Improving medical abortion: using mifepristone in combination with a prostaglandin analogue. (Ph.D. thesis. Stockholm: Department of Woman and Child Health, Division for Obstetrics and Gynaecology, Karolinska Institutet, October 2005.)